Use gene tools for disease, not designer babies, says panel
San Francisco
BREAKTHROUGH gene-editing technologies should be used for treating disease or disabilities, said a body of scientific specialists, not for changes such as creating a smarter, taller or better-looking child.
The US National Academy of Sciences issued a 200-page-plus report on Tuesday meant to serve as ethical guidelines for gene-editing technologies that are quickly becoming a mainstay in medical research. One such technology, known as Crispr, can elegantly snip out sections of DNA and replace them with other genetic instructions. Used to treat or potentially cure diseases caused by genetic defects, the technology has also raised worries about non-medical alterations that could be passed from one generation to the next.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO